Alpha 2.0
Login Register
» Articles » PMID: 20858102

Azacytidine As a Novel Agent in the Treatment of Acute Lymphoblastic Leukemia

Overview
Journal Leuk Lymphoma
Specialties Hematology
Oncology
Date 2010 Sep 23
PMID 20858102
Citations 8
Authors
Kristjan Paulson
Rajat Kumar
Arshad Ahsanuddin
Matthew D Seftel
Affiliations
Soon will be listed here.
Citing Articles

T/myeloid mixed-phenotype acute leukemia treated with venetoclax and decitabine: A case report.

Park S, Jeong E, Kang J, Lee G, Go S, Lee D World J Clin Cases. 2023; 11(26):6200-6205.

PMID: 37731550 PMC: 10507568. DOI: 10.12998/wjcc.v11.i26.6200.

Acute myelomonocytic leukemia and T-lymphoblastic lymphoma as simultaneous bilineage hematologic malignancy treated with decitabine: A case report.

Jeon S, Lee N, Cha S, Yhim H, Kwak J, Jang K World J Clin Cases. 2023; 11(21):5129-5135.

PMID: 37583856 PMC: 10424015. DOI: 10.12998/wjcc.v11.i21.5129.

Venetoclax Combined with Hypomethylating Agents for Treatment-Naïve B/Myeloid Mixed Phenotype Acute Leukemia.

Wu D, Chen W, Chen Z, Li Q Case Rep Hematol. 2021; 2021:6661109.

PMID: 33505737 PMC: 7815380. DOI: 10.1155/2021/6661109.

Inducible transgene expression in PDX models in vivo identifies KLF4 as a therapeutic target for B-ALL.

Liu W, Mrozek-Gorska P, Wirth A, Herold T, Schwarzkopf L, Pich D Biomark Res. 2020; 8:46.

PMID: 32944247 PMC: 7493381. DOI: 10.1186/s40364-020-00226-z.

Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant.

Rahmat L, Nguyen A, Abdulhaq H, Prakash S, Logan A, Mannis G Case Rep Hematol. 2018; 2018:6092646.

PMID: 30225152 PMC: 6129347. DOI: 10.1155/2018/6092646.